Pacer Advisors, Inc. Karuna Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$107.45 - $135.95 $69,842 - $88,367	-650 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$95.46 - $133.08 $32,456 - $45,247	-340 Reduced 34.34%	650 $78,000
Q4 2020 Jan 20, 2021	BUY	$75.23 - $109.23 $4,363 - $6,335	58 Added 6.22%	990 $101,000
Q3 2020 Oct 19, 2020	BUY	$71.31 - $109.74 $66,460 - $102,277	932 New	932 $72,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.